99 related articles for article (PubMed ID: 23076596)
1. Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma.
Taylor SS; Dodkin S; Papasouliotis K; Evans H; Graham PA; Belshaw Z; Westberg S; von Euler HP
J Feline Med Surg; 2013 Feb; 15(2):142-7. PubMed ID: 23076596
[TBL] [Abstract][Full Text] [Related]
2. Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma.
Larsdotter S; Nostell K; von Euler H
Vet J; 2015 Aug; 205(2):313-6. PubMed ID: 25744802
[TBL] [Abstract][Full Text] [Related]
3. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
4. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].
Aul C; Germing U; Gattermann N; Söhngen D; Heyll A
Dtsch Med Wochenschr; 1996 Sep; 121(37):1113-8. PubMed ID: 8925725
[TBL] [Abstract][Full Text] [Related]
6. Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma.
Brown RD; Joshua DE; Ioannidis RA; Kronenberg H
Aust N Z J Med; 1989 Jun; 19(3):226-32. PubMed ID: 2528340
[TBL] [Abstract][Full Text] [Related]
7. Is Serum Total LDH Evaluation Able to Differentiate between Alimentary Lymphoma and Inflammatory Bowel Disease in a Real World Clinical Setting?
Terragni R; Morselli-Labate AM; Vignoli M; Bottero E; Brunetti B; Saunders JH
PLoS One; 2016; 11(3):e0151641. PubMed ID: 26986208
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
[TBL] [Abstract][Full Text] [Related]
9. Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker.
Wang L; Sharif H; Saellström S; Rönnberg H; Eriksson S
BMC Vet Res; 2021 Sep; 17(1):316. PubMed ID: 34579716
[TBL] [Abstract][Full Text] [Related]
10. Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra.
Sharif H; Hagman R; Wang L; Eriksson S
Theriogenology; 2013 Jan; 79(1):17-23. PubMed ID: 23102844
[TBL] [Abstract][Full Text] [Related]
11. Thymidine kinase assay in canine lymphoma.
Elliott JW; Cripps P; Blackwood L
Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
[TBL] [Abstract][Full Text] [Related]
12. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
[TBL] [Abstract][Full Text] [Related]
13. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
[TBL] [Abstract][Full Text] [Related]
14. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
[TBL] [Abstract][Full Text] [Related]
15. Plasma matrix metalloproteinase-9 activity in cats with lymphoma.
Tamamoto T; Ohno K; Takahashi M; Fukushima K; Kanemoto H; Fujino Y; Tsujimoto H
Vet Comp Oncol; 2017 Mar; 15(1):1-5. PubMed ID: 24899544
[TBL] [Abstract][Full Text] [Related]
16. Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trial.
Brown RD; Joshua DE; Nelson M; Gibson J; Dunn J; MacLennan IC
Br J Haematol; 1993 Jun; 84(2):238-41. PubMed ID: 8398824
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation.
Gatt ME; Goldschmidt N; Kalichman I; Friedman M; Arronson AC; Barak V
Anticancer Res; 2015 May; 35(5):3019-26. PubMed ID: 25964590
[TBL] [Abstract][Full Text] [Related]
18. An in-house assay for serum deoxythymidine kinase.
Seah LH; Ton SH; Cheong SK; Hamidah NH
Malays J Pathol; 1991 Dec; 13(2):109-13. PubMed ID: 1823092
[TBL] [Abstract][Full Text] [Related]
19. [Serum thymidine kinase in the monitoring of lymphoma patients].
Rauhala A; Rantalaiho V; Almqvist A; Putkonen M
Duodecim; 1995; 111(5):428-34. PubMed ID: 8674444
[No Abstract] [Full Text] [Related]
20. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]